{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T09:11:58Z","timestamp":1764493918695,"version":"3.41.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","primarycare.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.pop.2016.04.007","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T06:16:10Z","timestamp":1471500970000},"page":"505-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Mastocytosis"],"prefix":"10.1016","volume":"43","author":[{"given":"Ayesha","family":"Abid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Curci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pop.2016.04.007_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000101711","article-title":"Mastocytosis: state of the art","volume":"74","author":"Horny","year":"2007","journal-title":"Pathobiology"},{"issue":"4","key":"10.1016\/j.pop.2016.04.007_bib2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pop.2016.04.007_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/joim.12410","article-title":"Mascytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease","volume":"279","author":"Gulen","year":"2015","journal-title":"J\u00a0Intern Med"},{"issue":"1","key":"10.1016\/j.pop.2016.04.007_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10428190400010775","article-title":"Mastocytosis: pathology, genetics and current options for therapy","volume":"46","author":"Valent","year":"2005","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.pop.2016.04.007_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11588890-000000000-00000","article-title":"Guidelines for the diagnosis and treatment of cutaneous mastocytosis in children","volume":"12","author":"Castells","year":"2011","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"10.1016\/j.pop.2016.04.007_bib6","first-page":"65","article-title":"Current concepts on diagnosis and treatment of mastocytosis","volume":"8","author":"Magliacane","year":"2014","journal-title":"Transl Med UniSa"},{"issue":"3","key":"10.1016\/j.pop.2016.04.007_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1590\/S0365-05962009000300002","article-title":"Mastocytosis","volume":"84","author":"Maluf","year":"2009","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.pop.2016.04.007_bib8","first-page":"159","article-title":"Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology","volume":"3","author":"Valent","year":"2013","journal-title":"Am J Cancer Res"},{"issue":"3","key":"10.1016\/j.pop.2016.04.007_bib9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ajh.23931","article-title":"Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management","volume":"90","author":"Pardanani","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pop.2016.04.007_bib10","first-page":"185","article-title":"Regulation of normal and neoplastic human mast cell development in mastocytosis","volume":"116","author":"Metcalfe","year":"2005","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.pop.2016.04.007_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nri2782","article-title":"Mast cell-orchestrated immunity to pathogens","volume":"10","author":"Abraham","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pop.2016.04.007_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1409760","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2016.04.007_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocystosis: a study on history, clinical feature and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.pop.2016.04.007_bib14","first-page":"288","article-title":"Mastocytosis and allergic disease","volume":"24","author":"Bonadonna","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.pop.2016.04.007_bib15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1182\/blood.V53.3.492.492","article-title":"Decreased production of mast cells in S1\/S1d mice","volume":"53","author":"Kitamura","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.pop.2016.04.007_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaci.2004.04.046","article-title":"The biology of Kit in disease and the application of pharmacogenetics","volume":"114","author":"Akin","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"year":"2011","series-title":"Mastocytosis-where are we now?","author":"McNeill","key":"10.1016\/j.pop.2016.04.007_bib17"},{"issue":"5","key":"10.1016\/j.pop.2016.04.007_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/ACI.0b013e3282a6443e","article-title":"Mastocytosis and allergy","volume":"7","author":"Greenhawt","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.pop.2016.04.007_bib19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1160\/TH11-05-0291","article-title":"Mast cells in atherosclerosis","volume":"106","author":"Bot","year":"2011","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.pop.2016.04.007_bib20","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bone.2011.07.004","article-title":"Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis","volume":"49","author":"Rossini","year":"2011","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.pop.2016.04.007_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D360F3R72D","article-title":"Mastocytosis with urticaria pigmentosa and osteoporosis","volume":"14","author":"Stein","year":"2008","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.pop.2016.04.007_bib22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/0002-9343(91)90214-I","article-title":"Hematologic manisfestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis","volume":"91","author":"Lawrence","year":"1991","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.pop.2016.04.007_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.iac.2006.05.002","article-title":"Diagnostic evaluation and classification of mastocytosis","volume":"26","author":"Valent","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"10.1016\/j.pop.2016.04.007_bib24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.5858\/2007-131-784-SMACCA","article-title":"Systemic mastocytosis: a concise clinical and laboratory review","volume":"131","author":"Patnaik","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.pop.2016.04.007_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/pde.12291","article-title":"Severity of cutaneous findings predict the presence of systemic symptoms in pediatric maculopapular cutaneous mastocytosis","volume":"31","author":"Barnes","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.pop.2016.04.007_bib26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.iac.2006.05.010","article-title":"Diagnostic value of tryptase in anaphylaxis and mastocytosis","volume":"26","author":"Schwartz","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"issue":"9","key":"10.1016\/j.pop.2016.04.007_bib27","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/modpathol.2011.84","article-title":"Evaluation of the WHO criteria for the classification of patients with mastocytosis","volume":"24","author":"S\u00e1nchez-Mu\u00f1oz","year":"2011","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.pop.2016.04.007_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ajh.23459","article-title":"Systemic mastocytosis in adults: 2012\u00a0Update on diagnosis, risk stratification, and management","volume":"87","author":"Pardanani","year":"2012","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.pop.2016.04.007_bib29","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1182\/blood-2012-07-442400","article-title":"Mast cell leukemia","volume":"121","author":"Georgin-Lavialle","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pop.2016.04.007_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2004.02.045","article-title":"Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms","volume":"114","author":"Valent","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.pop.2016.04.007_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/modpathol.2008.141","article-title":"Utility of the World Heath Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow","volume":"22","author":"Johnson","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pop.2016.04.007_bib32","article-title":"Persistent solitary lesion in an 8-month-old boy","author":"Semenov","year":"2013","journal-title":"Contemp Pediatr"},{"issue":"6","key":"10.1016\/j.pop.2016.04.007_bib33","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1200\/JCO.2012.41.9549","article-title":"Mast cell sarcoma: a rare and aggressive entity\u2013report of two cases and review of the literature","volume":"31","author":"Georgin-Lavialle","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.pop.2016.04.007_bib34","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.arcped.2012.04.021","article-title":"Bullous mastocytosis in infancy: a rare presentation","volume":"19","author":"Deverri\u00e8re","year":"2012","journal-title":"Arch Pediatr"},{"issue":"1","key":"10.1016\/j.pop.2016.04.007_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaip.2014.11.011","article-title":"Comprehensive allergy evaluation is useful in the subsequent care of patients with drug hypersensitivity reactions during anesthesia","volume":"3","author":"Guyer","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.pop.2016.04.007_bib36","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1213\/01.ANE.0000082993.84883.7D","article-title":"Anaphylaxis during the perioperative period","volume":"97","author":"Hepner","year":"2003","journal-title":"Anesth Analg"},{"issue":"8","key":"10.1016\/j.pop.2016.04.007_bib37","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A\u00a0novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.pop.2016.04.007_bib38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.all.0000235903.10548.63","article-title":"Mastocytosis and Hymenoptera venom allergy","volume":"6","author":"Ru\u00ebff","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.pop.2016.04.007_bib39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaci.2007.11.010","article-title":"Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis","volume":"121","author":"Gonz\u00e1lez de Olano","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.pop.2016.04.007_bib40","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1398-9995.2009.02045.x","article-title":"Prolonged high-dose omalizumab is required to control reactions to venom immunotherapy in mastocytosis","volume":"64","author":"Kontou-Fili","year":"2009","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.pop.2016.04.007_bib41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anai.2014.05.001","article-title":"Omalizumab effectively prevents recurrent refractory anaphylaxis in a patient with monoclonal mast cell activation syndrome","volume":"113","author":"Jagdis","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.pop.2016.04.007_bib42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajh.20211","article-title":"Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience","volume":"77","author":"Hennessy","year":"2004","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.pop.2016.04.007_bib43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8588(05)70301-4","article-title":"Treatment of systemic mast cell disorders","volume":"14","author":"Worobec","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"10.1016\/j.pop.2016.04.007_bib44","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000048190","article-title":"Treatment of cutaneous mastocytosis","volume":"127","author":"Wolff","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"10.1016\/j.pop.2016.04.007_bib45","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0091-6749(90)90067-E","article-title":"Cromolyn sodium in the management of systemic mastocytosis","volume":"85","author":"Horan","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.pop.2016.04.007_bib46","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM200402123500723","article-title":"Leukotriene-receptor inhibition for the treatment of systemic mastocytosis","volume":"350","author":"Tolar","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.pop.2016.04.007_bib47","doi-asserted-by":"crossref","first-page":"e26375","DOI":"10.1371\/journal.pone.0026375","article-title":"Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy","volume":"6","author":"Moura","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pop.2016.04.007_bib48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.2004.06300.x","article-title":"Diffuse cutaneous mastocytosis treated with psoralen photochemotherapy: case report and review of the literature","volume":"152","author":"Kinsler","year":"2005","journal-title":"Br J Dermatol"},{"issue":"4 Pt 2","key":"10.1016\/j.pop.2016.04.007_bib49","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0190-9622(84)70233-7","article-title":"Urticaria pigmentosa responsive to nifedipine","volume":"11","author":"Fairley","year":"1984","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.pop.2016.04.007_bib50","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2008-03-147785","article-title":"Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation","volume":"112","author":"Hoffmann","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pop.2016.04.007_bib51","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.leukres.2008.06.013","article-title":"Lenalidomide therapy in systemic mastocytosis","volume":"33","author":"Kluin-Nelemans","year":"2009","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.pop.2016.04.007_bib52","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0889-8588(05)70302-6","article-title":"New approaches to therapy for mastocytosis. A case for treatment with kit kinase inhibitors","volume":"14","author":"Longley","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.pop.2016.04.007_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anai.2009.11.006","article-title":"Current approaches to the diagnosis and treatment of systemic mastocytosis","volume":"104","author":"Bains","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"11","key":"10.1016\/j.pop.2016.04.007_bib54","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.leukres.2008.12.020","article-title":"Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis","volume":"33","author":"Vega-Ruiz","year":"2009","journal-title":"Leuk Res"},{"issue":"12","key":"10.1016\/j.pop.2016.04.007_bib55","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ajh.21894","article-title":"Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study","volume":"85","author":"Paul","year":"2010","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.pop.2016.04.007_bib56","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2362.2008.02036.x","article-title":"Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis","volume":"38","author":"Aichberger","year":"2008","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"10.1016\/j.pop.2016.04.007_bib57","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/1078-0432.CCR-08-0366","article-title":"Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis","volume":"14","author":"Verstovsek","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"29","key":"10.1016\/j.pop.2016.04.007_bib58","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1200\/JCO.2014.55.2018","article-title":"Hematopoietic stem-cell transplantation for advanced systemic mastocytosis","volume":"32","author":"Ustun","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"34","key":"10.1016\/j.pop.2016.04.007_bib59","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.2174\/138161211798357827","article-title":"Mast cells as targets of pimecrolimus","volume":"17","author":"Ma","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pop.2016.04.007_bib60","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1182\/blood-2013-01-453183","article-title":"How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage)","volume":"121","author":"Pardanani","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.pop.2016.04.007_bib61","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","article-title":"Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria","volume":"27","author":"Valent","year":"2003","journal-title":"Leuk Res"},{"issue":"26","key":"10.1016\/j.pop.2016.04.007_bib62","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1182\/blood-2010-08-292144","article-title":"How I treat patients with advanced systemic mastocytosis","volume":"116","author":"Valent","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pop.2016.04.007_bib63","first-page":"94","article-title":"Splenectomy in the management of systemic mast cell disease","volume":"107","author":"Friedman","year":"1990","journal-title":"Surgery"},{"issue":"40","key":"10.1016\/j.pop.2016.04.007_bib64","doi-asserted-by":"crossref","first-page":"e1414","DOI":"10.1097\/MD.0000000000001414","article-title":"A\u00a0French national survey on clotting disorders in mastocytosis","volume":"94","author":"Carvalhosa","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.pop.2016.04.007_bib65","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.jaci.2006.04.016","article-title":"Extracutaneous mastocytoma","volume":"117","author":"Castells","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454316300197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454316300197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:02:49Z","timestamp":1749063769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454316300197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0095454316300197"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2016.04.007","relation":{},"ISSN":["0095-4543"],"issn-type":[{"type":"print","value":"0095-4543"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mastocytosis","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2016.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}